Comparative efficacy and safety of axitinib versus sorafenib in metastatic renal cell carcinoma: a systematic review and meta-analysis

OBJECTIVE: This study was performed to evaluate the comparative efficacy and safety of axitinib and sorafenib in the therapy of metastatic renal cell carcinoma. MATERIALS AND METHODS: Eligible studies were searched from PubMed, Embase, and Future Medicine databases. The pooled hazard ratios and rela...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Hai, Man, Libo, Li, Guizhong, Huang, Guanglin, Wang, Jianwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4907737/
https://www.ncbi.nlm.nih.gov/pubmed/27354814
http://dx.doi.org/10.2147/OTT.S100706

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4907737/
https://www.ncbi.nlm.nih.gov/pubmed/27354814
http://dx.doi.org/10.2147/OTT.S100706

Ejemplares similares